Company Overview and News

 
Paterson Project Update

2017-08-17 londonstockexchange
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).
Upvote Downvote

 
Update on Havieron Project

2017-06-21 londonstockexchange
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).
Upvote Downvote

 
Antipa Minerals to update on deal with Rio Tinto

2017-04-06 proactiveinvestors.com.au
Antipa Minerals (ASX:AZY) has been granted a trading halt by the ASX, with its shares placed in pre-open.
Upvote Downvote

 
Antipa Minerals Ltd to increase cash balance

2016-10-25 proactiveinvestors.com.au
Antipa Minerals Ltd (ASX:AZY) has been granted a trading halt by the ASX pending details of a capital raising.
Upvote Downvote

 
Antipa Minerals sets sail for raising

2016-10-23 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Tuesday 25th October, or earlier if an announcement is made to the market.
Upvote Downvote

 
Acquisition of Havieron Gold Project

2016-09-26 londonstockexchange
Greatland Gold plc (LON:GGP), the London Stock Exchange AIM listed precious and base metals exploration and development business, is pleased to announce that it has entered into an agreement to acquire 100% of the Havieron Gold Project in Western Australia.
Upvote Downvote

 
Sipa Resources Ltd to raise $4.2M for Western Australia copper-gold project

2016-08-21 proactiveinvestors.com.au
Sipa Resources Ltd (ASX:SRI) is focused on Uganda where it has over 6,500 square kilometres of exploration tenements.
Upvote Downvote

 
Antipa Minerals Ltd awaits gold-copper assays from producing district

2016-08-09 proactiveinvestors.com.au
Antipa Minerals Ltd (ASX:AZY) has completed an 8029-metre Phase 1 drilling program at the Minyari Deposit of the North Telfer Project in Western Australia’s Paterson Province. The project is located just 20 kilometres north of the Telfer mine owned by Newcrest Mining Ltd (ASX:NCM) where 520,309 ounces of gold and 23,119 tonnes of copper were produced in FY2015. In July, Antipa had announced results from the first 11 holes at the Minyari Deposit which included 35 metres at 3.
Upvote Downvote

 
Antipa Minerals Ltd has high grade gold hits at North Telfer Project

2016-07-20 proactiveinvestors.com.au
Antipa Minerals Ltd (ASX:AZY) has received assay results revealing high-grade gold intersections on multiple drill sections from early drilling at the North Telfer Project in Western Australia. Conveniently, the project is located just 20 kilometres north of the Telfer gold and copper mines in the Great Sandy Desert in the East Pilbara region of Western Australia, owned by Newcrest Mining Ltd (ASX:NCM).
Upvote Downvote

 
Sipa Resources Ltd gears up to drill for copper-gold in Paterson Province

2016-07-15 proactiveinvestors.com.au
Sipa Resources Ltd (ASX:SRI) is focused on Uganda where it has over 6,500 square kilometres of exploration tenements.
Upvote Downvote

 
Antipa identifies North Telfer targets

2016-07-06 news.theage.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.
Upvote Downvote

 
Antipa identifies North Telfer targets

2016-07-06 news.smh.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.
Upvote Downvote

 
Antipa Minerals Ltd in an ASX trading halt

2016-06-22 proactiveinvestors.com.au
Antipa Minerals Ltd (ASX:AZY) has been granted a trading halt by the ASX, allowing the company time to respond to a price and volume query. Intra-day before the halt, the shares were up 16.3% to $0.051, with more than 18 million shares changing hands. The halt will remain in place until the opening of trade on Friday 24th June 2016, or earlier if an announcement is made to the market.
Upvote Downvote

 
Juniors rattle tin for funds

2016-05-23 businessnews.com.au
Listen to podcasts covering breaking news, items of interest and our Success & Leadership Series events. A wide range of topics covered by our well renowned reporters and WA business leaders. Subscribe on iTunes for updates as they happen. Click here for more
Upvote Downvote

 
Appendix 3B

2016-05-13 asx.com.au
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...